News Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 00:02:30 03/07/2026 HKT			5-day change	1st Jan Change
301.78 ^USD	+1.58%		+1.09%	-0.48%

07-01	Activist investors make bigger push for campaigns in H1, seek more M&A	RE
06-03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM

All News

Mentions Relevance

06-03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
05-19	Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM
05-18	Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround	MT
05-18	Elliott Investment Management LP Urges Improvement In Share Price And Value Creation for Shareholders	CI
05-18	Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports	RE
05-18	Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports	RE
05-18	Activist Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories - WSJ	RE
05-15	Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says	MT
05-11	Bio-Rad to Participate in Upcoming Investor Conferences	AQ
05-08	Bio-Rad to Participate in Upcoming Investor Conferences	BU
05-01	Bio-Rad Laboratories, Inc., Q1 2026 Earnings Call, Apr 30, 2026
05-01	Bio Rad Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05-01	Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises	MT
05-01	Bio-Rad: Q1 Earnings Snapshot	AQ
05-01	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q1 Revenue $592.1M, vs. FactSet Est of $589.9M	MT
05-01	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q1 Adjusted EPS $1.89 per Share, vs. FactSet Est of $1.97	MT
05-01	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
05-01	Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-01	Bio-Rad Reports First-Quarter 2026 Financial Results	BU
04-17	Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026	BU
04-07	Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $300 From $375	MT
02-14	UBS Adjusts Price Target on Bio-Rad Laboratories to $335 From $350, Maintains Buy Rating	MT
02-13	Bio-Rad Laboratories, Inc., Q4 2025 Earnings Call, Feb 12, 2026
02-13	Bio-Rad Laboratories Q4 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours	MT
02-13	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M	MT